<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mantile F</submitter><funding>NIAID NIH HHS</funding><pagination>e101474</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4077797</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(7)</volume><pubmed_abstract>The development of active immunotherapy for Alzheimer's disease (AD) requires the identification of immunogens that can ensure a high titer antibody response toward Aβ, while minimizing the risks of adverse reactions. Multimeric protein (1-11)E2 induces a robust and persistent antibody response to Aβ in mice, when formulated in Freund's adjuvant. The goal of this translational study was to evaluate the immunogenicity of (1-11)E2 formulated in alum (Alhydrogel 2%), or in a squalene oil-in-water emulsion (AddaVax), or without adjuvant. A IgG1-skewed isotype distribution was observed for the anti-Aβ antibodies generated in mice immunized with either the non-adjuvanted or the adjuvanted vaccine, indicating that (1-11)E2 induces a Th2-like response in all tested conditions. Both Alhydrogel 2% a</pubmed_abstract><journal>PloS one</journal><pubmed_title>Alum and squalene-oil-in-water emulsion enhance the titer and avidity of anti-Aβ antibodies induced by multimeric protein antigen (1-11)E2, preserving the Igg1-skewed isotype distribution.</pubmed_title><pmcid>PMC4077797</pmcid><funding_grant_id>R01 AI074379</funding_grant_id><pubmed_authors>Ottonello S</pubmed_authors><pubmed_authors>Trovato M</pubmed_authors><pubmed_authors>Santoni A</pubmed_authors><pubmed_authors>De Berardinis P</pubmed_authors><pubmed_authors>Barba P</pubmed_authors><pubmed_authors>Prisco A</pubmed_authors><pubmed_authors>Mantile F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Alum and squalene-oil-in-water emulsion enhance the titer and avidity of anti-Aβ antibodies induced by multimeric protein antigen (1-11)E2, preserving the Igg1-skewed isotype distribution.</name><description>The development of active immunotherapy for Alzheimer's disease (AD) requires the identification of immunogens that can ensure a high titer antibody response toward Aβ, while minimizing the risks of adverse reactions. Multimeric protein (1-11)E2 induces a robust and persistent antibody response to Aβ in mice, when formulated in Freund's adjuvant. The goal of this translational study was to evaluate the immunogenicity of (1-11)E2 formulated in alum (Alhydrogel 2%), or in a squalene oil-in-water emulsion (AddaVax), or without adjuvant. A IgG1-skewed isotype distribution was observed for the anti-Aβ antibodies generated in mice immunized with either the non-adjuvanted or the adjuvanted vaccine, indicating that (1-11)E2 induces a Th2-like response in all tested conditions. Both Alhydrogel 2% a</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014</publication><modification>2025-05-29T22:08:45.654Z</modification><creation>2025-05-29T22:08:45.654Z</creation></dates><accession>S-EPMC4077797</accession><cross_references><pubmed>24983378</pubmed><doi>10.1371/journal.pone.0101474</doi></cross_references></HashMap>